Proteolytic activation of the cytotoxic phenotype during human NK cell development

Journal of Immunology

Volumn 183, Issue 2, 2009, Pages 803-813

  Meade, Josephine L ^a   Wilson, Erica B ^a   Holmes, Tim D ^a   De Wynter, Erika A ^a   Brett, Peter ^b   Straszynski, Liz ^a   Ballard, Paul A S ^c   Trapani, Joseph A ^d   McDermott, Michael F ^a   Cook, Graham P ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c FRIARAGE HOSPITAL   (United Kingdom)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; DIPEPTIDYL PEPTIDASE I; ENZYME PRECURSOR; GRANZYME B; INTERLEUKIN 15; PERFORIN; PROTEINASE; STEM CELL FACTOR; CASPASE; GRANZYME; MEMBRANE ANTIGEN; PEPTIDE HYDROLASE;

ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL MATURATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEFICIENCY; ENZYME SYNTHESIS; EXOCYTOSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; TARGET CELL; CELL CULTURE; CYTOLOGY; CYTOTOXICITY; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SECRETORY VESICLE;

ANTIGENS, SURFACE; CASPASES; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; EXOCYTOSIS; GRANZYMES; HUMANS; INTERLEUKIN-15; KILLER CELLS, NATURAL; PEPTIDE HYDROLASES; PERFORIN; SECRETORY VESICLES; STEM CELL FACTOR;

EID: 70249150088     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0713829     Document Type: Article

References (56)

1. Russell, J. H., and T. J. Ley. 2002. Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 20: 323-370.
2. Grossman, W. J., P. A. Revell, Z. H. Lu, H. Johnson, A. J. Bredemeyer, and T. J. Ley. 2003. The orphan granzymes of humans and mice. Curr. Opin. Immunol. 15: 544-552.
3. Smyth, M. J., M. J. McGuire, and K. Y. Thia. 1995. Expression of recombinant human granzyme B. A processing and activation role for dipeptidyl peptidase I. J. Immunol. 154: 6299-6305.
4. Kummer, J. A., A. M. Kamp, F. Citarella, A. J. Horrevoets, and C. E. Hack. 1996. Expression of human recombinant granzyme A zymogen and its activation by the cysteine proteinase cathepsin C. J. Biol. Chem. 271: 9281-9286.
5. Wilharm, E., M. A. Parry, R. Friebel, H. Tschesche, G. Matschiner, C. P. Sommerhoff, and D. E. Jenne. 1999. Generation of catalytically active granzyme K from Escherichia coli inclusion bodies and identification of efficient granzyme K inhibitors in human plasma. J. Biol. Chem. 274: 27331-27337. (Pubitemid 129520265)
6. Fellows, E., S. Gil-Parrado, D. E. Jenne, and F. C. Kurschus. 2007. Natural killer cell-derived human granzyme H induces an alternative, caspase-independent cell-death program. Blood 110: 544-552.
7. Pham, C. T., and T. J. Ley. 1999. Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc. Natl. Acad. Sci. USA 96: 8627-8632.
8. Meade, J. L., E. A. de Wynter, P. Brett, S. M. Sharif, C. G. Woods, A. F. Markham, and G. P. Cook. 2006. A family with Papillon-Lefevre syndrome reveals a requirement for cathepsin C in granzyme B activation and NK cell cytolytic activity. Blood 107: 3665-3668.
9. Lundgren, T., R. S. Parhar, S. Renvert, and D. N. Tatakis. 2005. Impaired cytotoxicity in Papillon-Lefevre syndrome. J. Dental Res. 84: 414-417.
10. Sutton, V. R., N. J. Waterhouse, K. A. Browne, K. Sedelies, A. Ciccone, D. Anthony, A. Koskinen, A. Mullbacher, and J. A. Trapani. 2007. Residual active granzyme B in cathepsin C-null lymphocytes is sufficient for perforin-dependent target cell apoptosis. J. Cell Biol. 176: 425-433.
11. Pham, C. T., J. L. Ivanovich, S. Z. Raptis, B. Zehnbauer, and T. J. Ley. 2004. Papillon-Lefevre syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin C/dipeptidyl peptidase I deficiency in humans. J. Immunol. 173: 7277-7281.
12. Dahl, S. W., T. Halkier, C. Lauritzen, I. Dolenc, J. Pedersen, V. Turk, and B. Turk. 2001. Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing. Biochemistry 40: 1671-1678.
13. Voskoboinik, I., M. J. Smyth, and J. A. Trapani. 2006. Perforin-mediated target-cell death and immune homeostasis. Nat. Rev. Immunol. 6: 940-952.
14. Uellner, R., M. J. Zvelebil, J. Hopkins, J. Jones, L. K. MacDougall, B. P. Morgan, E. Podack, M. D. Waterfield, and G. M. Griffiths. 1997. Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid-binding C2 domain. EMBO J. 16: 7287-7296.
15. Lodolce, J. P., D. L. Boone, S. Chai, R. E. Swain, T. Dassopoulos, S. Trettin, and A. Ma. 1998. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9: 669-676.
16. Kennedy, M. K., M. Glaccum, S. N. Brown, E. A. Butz, J. L. Viney, M. Embers, N. Matsuki, K. Charrier, L. Sedger, C. R. Willis, K. Brasel, et al. 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191: 771-780.
17. + hematopoietic progenitor cells. Blood 87: 2632-2640.
18. Muench, M. O., L. Humeau, B. Paek, T. Ohkubo, L. L. Lanier, C. T. Albanese, and A. Barcena. 2000. Differential effects of interleukin-3, interleukin-7, interleukin 15, and granulocyte-macrophage colony-stimulating factor in the generation of natural killer and B cells from primitive human fetal liver progenitors. Exp. Hematol. 28: 961-973.
19. + human natural killer cell progenitor that responds to interleukin-15. Blood 92: 3647-3657.
20. Carayol, G., C. Robin, J. H. Bourhis, A. Bennaceur-Griscelli, S. Chouaib, L. Coulombel, and A. Caignard. 1998. NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions. Eur. J. Immunol. 28: 1991-2002.
21. + cell precursors towards NK cells and acquisition of surface killer Ig-like receptors. Eur. J. Immunol. 33: 3439-3447.
22. + cells. Bone Marrow Transplant. 23: 1191-1196.
23. Freud, A. G., and M. A. Caligiuri. 2006. Human natural killer cell development. Immunol. Rev. 214: 56-72. (Pubitemid 44707902)
24. Hewitt, C., D. McCormick, G. Linden, D. Turk, I. Stern, I. Wallace, L. Southern, L. Zhang, R. Howard, P. Bullon, et al. 2004. The role of cathepsin C in Papillon-Lefevre syndrome, prepubertal periodontitis, and aggressive periodontitis. Hum. Mut. 23: 222-228.
25. + T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281: 65-78.
26. Ewen, C., K. P. Kane, I. Shostak, P. J. Griebel, E. M. Bertram, T. H. Watts, R. C. Bleackley, and J. E. McElhaney. 2003. A novel cytotoxicity assay to evaluate antigen-specific CTL responses using a colorimetric substrate for Granzyme B. J. Immunol. Methods 276: 89-101.
27. Methot, N., J. Rubin, D. Guay, C. Beaulieu, D. Ethier, T. J. Reddy, D. Riendeau, and M. D. Percival. 2007. Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing. J. Biol. Chem. 282: 20836-20846.
28. Sedelies, K. A., T. J. Sayers, K. M. Edwards, W. Chen, D. G. Pellicci, D. I. Godfrey, and J. A. Trapani. 2004. Discordant regulation of granzyme H and granzyme B expression in human lymphocytes. J. Biol. Chem. 279: 26581-26587.
29. Hart, T. C., P. S. Hart, D. W. Bowden, M. D. Michalec, S. A. Callison, S. J. Walker, Y. Zhang, and E. Firatli. 1999. Mutations of the cathepsin C gene are responsible for Papillon-Lefevre syndrome. J. Med. Genet. 36: 881-887. (Pubitemid 30003843)
30. Strehlau, J., M. Pavlakis, M. Lipman, M. Shapiro, L. Vasconcellos, W. Harmon, and T. B. Strom. 1997. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc. Natl. Acad. Sci. USA 94: 695-700. (Pubitemid 27053696)
31. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274.
32. Moretta, L., and A. Moretta. 2004. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J. 23: 255-259. (Pubitemid 38294490)
33. Grossman, W. J., J. W. Verbsky, B. L. Tollefsen, C. Kemper, J. P. Atkinson, and T. J. Ley. 2004. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 104: 2840-2848.
34. Liu, L., A. Chahroudi, G. Silvestri, M. E. Wernett, W. J. Kaiser, J. T. Safrit, A. Komoriya, J. D. Altman, B. Z. Packard, and M. B. Feinberg. 2002. Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates. Nat. Med. 8: 185-189.
35. - bone marrow progenitors. J. Immunol. 150: 5263-5269.
36. - primitive progenitors in long-term bone marrow culture. Blood 80: 2182-2187.
37. Silva, M. R., R. Hoffman, E. F. Srour, and J. L. Ascensao. 1994. Generation of human natural killer cells from immature progenitors does not require marrow stromal cells. Blood 84: 841-846.
38. Kundig, T. M., H. Schorle, M. F. Bachmann, H. Hengartner, R. M. Zinkernagel, and I. Horak. 1993. Immune responses in interleukin-2-deficient mice. Science 262: 1059-1061.
39. Grzywacz, B., N. Kataria, M. Sikora, R. A. Oostendorp, E. A. Dzierzak, B. R. Blazar, J. S. Miller, and M. R. Verneris. 2006. Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. Blood 108: 3824-3833.
40. Mallen-St Clair, J., G. P. Shi, R. E. Sutherland, H. A. Chapman, G. H. Caughey, and P. J. Wolters. 2006. Cathepsins L and S are not required for activation of dipeptidyl peptidase I (cathepsin C) in mice. Biol. Chem. 387: 1143-1146.
41. +-ATPase, on CTL-mediated cytotoxicity. J. Immunol. 153: 3938-3947.
42. Trambas, C., F. Gallo, D. Pende, S. Marcenaro, L. Moretta, C. De Fusco, A. Santoro, L. Notarangelo, M. Arico, and G. M. Griffiths. 2005. A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin. Blood 106: 932-937.
43. Katano, H., M. A. Ali, A. C. Patera, M. Catalfamo, E. S. Jaffe, H. Kimura, J. K. Dale, S. E. Straus, and J. I. Cohen. 2004. Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Blood 103: 1244-1252.
44. Risma, K. A., R. W. Frayer, A. H. Filipovich, and J. Sumegi. 2006. Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis. J. Clin. Invest. 116: 182-192.
45. Isaaz, S., K. Baetz, K. Olsen, E. Podack, and G. M. Griffiths. 1995. Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway. Eur. J. Immunol. 25: 1071-1079.
46. Stepp, S. E., R. Dufourcq-Lagelouse, F. Le Deist, S. Bhawan, S. Certain, P. A. Mathew, J. I. Henter, M. Bennett, A. Fischer, G. de Saint Basile, and V. Kumar. 1999. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 286: 1957-1959.
47. Feldmann, J., I. Callebaut, G. Raposo, S. Certain, D. Bacq, C. Dumont, N. Lambert, M. Ouachee-Chardin, G. Chedeville, H. Tamary, et al. 2003. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 115: 461-473.
48. zur Stadt, U., S. Schmidt, B. Kasper, K. Beutel, A. S. Diler, J. I. Henter, H. Kabisch, R. Schneppenheim, P. Nurnberg, G. Janka, and H. C. Hennies. 2005. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum. Mol. Genet. 14: 827-834.
49. Ohadi, M., M. R. Lalloz, P. Sham, J. Zhao, A. M. Dearlove, C. Shiach, S. Kinsey, M. Rhodes, and D. M. Layton. 1999. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. Am. J. Hum. Genet. 64: 165-171.
50. Kuribayashi, M., H. Yamada, T. Ohmori, M. Yanai, and T. Imoto. 1993. Endopeptidase activity of cathepsin C, dipeptidyl aminopeptidase I, from bovine spleen. J. Biochem. 113: 441-449. (Pubitemid 23136040)
51. Turk, D., V. Janjic, I. Stern, M. Podobnik, D. Lamba, S. W. Dahl, C. Lauritzen, J. Pedersen, V. Turk, and B. Turk. 2001. Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases. EMBO J. 20: 6570-6582.
52. Wolters, P. J., C. T. Pham, D. J. Muilenburg, T. J. Ley, and G. H. Caughey. 2001. Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice. J. Biol. Chem. 276: 18551-18556.
53. Adkison, A. M., S. Z. Raptis, D. G. Kelley, and C. T. Pham. 2002. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J. Clin. Invest. 109: 363-371.
54. Bossi, G., and G. M. Griffiths. 2005. CTL secretory lysosomes: biogenesis and secretion of a harmful organelle. Semin. Immunol. 17: 87-94.
55. Sivori, S., M. Falco, E. Marcenaro, S. Parolini, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta. 2002. Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. Proc. Natl. Acad. Sci. USA 99: 4526-4531.
56. Freud, A. G., A. Yokohama, B. Becknell, M. T. Lee, H. C. Mao, A. K. Ferketich, and M. A. Caligiuri. 2006. Evidence for discrete stages of human natural killer cell differentiation in vivo. J. Exp. Med. 203: 1033-1043.